Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pseudomonas and bronchial diseases].

C Mayaud1,

  • 1Service de pneumologie et de réanimation respiratoire, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France. charles.mayaud@tnn.ap-hop-paris.fr

Medecine Et Maladies Infectieuses
|May 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pulmonary manifestations in HIV-infected patients: a diagnostic approach].

Revue des maladies respiratoires·2014
Same author

Single event time series analysis in a binary karst catchment evaluated using a groundwater model (Lurbach system, Austria).

Journal of hydrology·2014
Same author

[HIV in the lung from 1982 to 2013].

Revue des maladies respiratoires·2014
Same author

Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections--the Fluco French cohort.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2013
Same author

[Aetiology of AFB negative pneumonias in hospitalized HIV patients in Dakar].

Revue des maladies respiratoires·2010
Same author

Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy?

The Journal of antimicrobial chemotherapy·2009

Pseudomonas aeruginosa (Pa) infection significantly worsens chronic lung diseases like cystic fibrosis. Early detection and eradication of Pa are crucial in cystic fibrosis but not yet proven for other chronic bronchial conditions.

Area of Science:

  • Pulmonary Medicine
  • Microbiology
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa (Pa) acquisition, colonization, and infection pose risks in chronic bronchial diseases, varying by condition and stage.
  • Pa involvement signifies a critical disease evolution, particularly evident in cystic fibrosis.
  • Factors influencing Pa risk and disease progression are multifaceted.

Purpose of the Study:

  • To explore the varying impact of Pseudomonas aeruginosa on different chronic bronchial diseases.
  • To highlight the mechanisms of Pa colonization and virulence in the respiratory tract.
  • To discuss the implications of Pa infection on disease prognosis and management strategies.

Main Methods:

  • Literature review and synthesis of existing research on Pseudomonas aeruginosa in chronic lung diseases.

Related Experiment Videos

  • Analysis of Pa adherence, biofilm formation, and virulence factor production.
  • Examination of clinical outcomes and prognostic significance of Pa in various conditions.

    • Main Results:

    • Pa colonization progresses from adherence to structured biofilms, supporting chronic infection.
    • Virulence factors produced by Pa cause host cell destruction and inflammation, exacerbating chronic respiratory diseases.
    • In cystic fibrosis, Pa presence is a major prognostic indicator, necessitating early eradication strategies.

    Conclusions:

    • Chronic Pa suppuration impacts systemic health, requiring multidisciplinary management.
    • Early detection and eradication of Pseudomonas aeruginosa are recommended in cystic fibrosis to prevent chronicity.
    • Current management strategies for early Pa detection and eradication are not yet established for other chronic bronchial diseases.